For example, clinical trials of semaglutide and tirzepatide report dyspepsia occurring in approximately 3-9% of patients, with GERD and belching/eructation also noted in some product labels
HR Jolt Posts Handling GLP-1 Drugs Coverage Handling GLP-1 Drugs Coverage Get a List of the Best HRIS Software for Your Company Get a tailored vendor shortlist based on your unique needs Personalized 1:1 help from HR software expert Save time and money with expert research HR Trend Spotlight: Handling the Coverage of GLP-1 Drugs Employers are navigating the complexities of covering GLP-1 weight-loss drugs, such as Ozempic and Wegovy, in their healthcare plans
Confirmed findings are submitted to NebraskaMushrooms.org, a publicly accessible database that provides information on fungal species found throughout the state
The demand for GLP-1 drugs like Semaglutide remains high, driven by their effectiveness not just for diabetes and weight loss, but also for other conditions like heart disease and kidney disease
Without it, old eating patterns can return more easily than after a purely behavioural intervention
